{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:47:27Z","timestamp":1778165247651,"version":"3.51.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>There remains debate over the optimal mitral valve replacement (MVR) option for patients aged 50\u201370 years. The objective of this study was to retrospectively compare the long-term outcomes of mechanical and bioprosthetic MVR in this patient population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Data from patients undergoing MVR between 2004 and 2018 were retrospectively reviewed. The primary outcome was all-cause mortality. Secondary outcomes included perioperative and late morbidity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Two hundred and eight-six propensity-matched patients (n\u2009=\u2009143 mechanical; n\u2009=\u2009143 bioprosthetic) aged 50\u201370 years were included in the final analysis. Maximum follow-up was 15.8\u2009years. There was no significant difference in all-cause mortality between the groups at 30\u2009days, 1\u2009year, 5\u2009years, 10\u2009years, and at the longest follow-up. Patients who underwent mechanical MVR experienced significantly lower rates of postoperative atrial fibrillation (P\u2009=\u20090.001). There were no significant differences in rates of sepsis, acute kidney injury, superficial and deep sternal wound infection, mediastinal bleeding, and permanent pacemaker implantation. At the longest follow-up, there were no differences in myocardial infarction, stroke, heart failure or overall rehospitalization. At the same time point, there was an increased rate of MVR in patients receiving a bioprosthetic valve (P\u2009=\u20090.015).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Survival following mechanical and bioprosthetic MVR in patients 50\u201370\u2009years of age is similar to up to 15\u2009years of follow-up. Bioprosthetic MVR is associated with an increased risk of repeat MVR. Mechanical MVR is not associated with an increased risk of stroke. Valve selection in this patient population requires diligent consideration of structural valve deterioration and subsequent reoperation risk as well as bleeding and thromboembolic risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejcts\/ezae283","type":"journal-article","created":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T23:00:36Z","timestamp":1724281236000},"source":"Crossref","is-referenced-by-count":4,"title":["Tissue versus mechanical mitral valve replacement in patients aged 50\u201370: a propensity-matched analysis"],"prefix":"10.1093","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7277-6188","authenticated-orcid":false,"given":"Nicholas M","family":"Fialka","sequence":"first","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, University of Alberta , Edmonton, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeline R","family":"Watkins","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry, University of Alberta , Edmonton, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar","family":"Alam","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry, University of Alberta , Edmonton, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7146-4337","authenticated-orcid":false,"given":"Ryaan","family":"EL-Andari","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, University of Alberta , Edmonton, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3351-2593","authenticated-orcid":false,"given":"Jimmy J H","family":"Kang","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, University of Alberta , Edmonton, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhe","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, University of Alberta , Edmonton, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7067-3102","authenticated-orcid":false,"given":"Sabin J","family":"Bozso","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, University of Alberta , Edmonton, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-8336","authenticated-orcid":false,"given":"Michael C","family":"Moon","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, University of Alberta , Edmonton, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2050-6717","authenticated-orcid":false,"given":"Jeevan","family":"Nagendran","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, University of Alberta , Edmonton, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"2024082420210988100_ezae283-B1","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0140-6736(16)00558-4","article-title":"Mitral valve disease\u2014current management and future challenges","volume":"387","author":"Nishimura","year":"2016","journal-title":"Lancet"},{"key":"2024082420210988100_ezae283-B2","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart Disease and Stroke Statistics-2021 update: a report From the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"2024082420210988100_ezae283-B3","first-page":"E72","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2024082420210988100_ezae283-B4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/jama.2015.3164","article-title":"Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years","volume":"313","author":"Chikwe","year":"2015","journal-title":"JAMA"},{"key":"2024082420210988100_ezae283-B5","doi-asserted-by":"crossref","first-page":"e13018","DOI":"10.1111\/sji.13018","article-title":"A review of the immune response stimulated by xenogenic tissue heart valves","volume":"93","author":"Bozso","year":"2021","journal-title":"Scand J Immunol"},{"key":"2024082420210988100_ezae283-B6","doi-asserted-by":"crossref","first-page":"e018506","DOI":"10.1161\/JAHA.120.018506","article-title":"Degeneration of Bioprosthetic Heart Valves: update 2020","volume":"9","author":"Kostyunin","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2024082420210988100_ezae283-B7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"2024082420210988100_ezae283-B8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jtcvs.2013.08.028","article-title":"Mechanical versus bioprosthetic mitral valve replacement in patients &lt;65 years old","volume":"147","author":"Kaneko","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"2024082420210988100_ezae283-B9","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezac073","article-title":"Biological or mechanical mitral valve replacement in patients 50-70 years of age-a propensity-adjusted analysis","volume":"62","author":"Leviner","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024082420210988100_ezae283-B10","first-page":"95","article-title":"Bioprosthetic versus mechanical valves for mitral valve replacement in patients","author":"Ahmed","year":"2023","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2024082420210988100_ezae283-B11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/jocs.14478","article-title":"Mitral valve prosthesis choice in patients","volume":"35","author":"Yanagawa","year":"2020","journal-title":"J Card Surg"},{"key":"2024082420210988100_ezae283-B12","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1056\/NEJMoa1613792","article-title":"Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement","volume":"377","author":"Goldstone","year":"2017","journal-title":"N Engl J Med"},{"key":"2024082420210988100_ezae283-B13","doi-asserted-by":"crossref","first-page":"904958","DOI":"10.3389\/fcvm.2022.904958","article-title":"Bioprosthetic vs. mechanical mitral valve replacement for rheumatic heart disease in patients aged 50-70 Years","volume":"9","author":"Yu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2024082420210988100_ezae283-B14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejcts.2006.06.013","article-title":"Mechanical versus bioprosthetic valve replacement in middle-aged patients","volume":"30","author":"Kulik","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024082420210988100_ezae283-B15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jtcvs.2021.03.033","article-title":"Bioprosthetic versus mechanical mitral valve replacements in patients with rheumatic heart disease","volume":"165","author":"Chen","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024082420210988100_ezae283-B16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/clc.23407","article-title":"Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years","volume":"43","author":"Hu","year":"2020","journal-title":"Clin Cardiol"},{"key":"2024082420210988100_ezae283-B17","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(02)08272-7","article-title":"Quantification of the completeness of follow-up","volume":"359","author":"Clark","year":"2002","journal-title":"Lancet"},{"key":"2024082420210988100_ezae283-B18","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0735-1097(00)00834-2","article-title":"Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial","volume":"36","author":"Hammermeister","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2024082420210988100_ezae283-B19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/CIRCULATIONAHA.108.778886","article-title":"Prosthetic heart valves: selection of the optimal prosthesis and long-term management","volume":"119","author":"Pibarot","year":"2009","journal-title":"Circulation"},{"key":"2024082420210988100_ezae283-B20","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.athoracsur.2017.05.001","article-title":"Outcomes of early mitral valve reoperation in the medicare population","volume":"104","author":"Kwedar","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2024082420210988100_ezae283-B21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/heartjnl-2017-312047","article-title":"Contemporary outcomes in reoperative mitral valve surgery","volume":"104","author":"Mehaffey","year":"2018","journal-title":"Heart"},{"key":"2024082420210988100_ezae283-B22","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.cjca.2020.09.001","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"key":"2024082420210988100_ezae283-B23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.jvca.2018.09.039","article-title":"Society of Cardiovascular Anesthesiologists\/European Association of Cardiothoracic Anaesthetists Practice Advisory for the management of perioperative atrial fibrillation in patients undergoing cardiac surgery","volume":"33","author":"O'Brien","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2024082420210988100_ezae283-B24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.jvca.2015.08.003","article-title":"New-onset atrial fibrillation after cardiac surgery: pathophysiology, prophylaxis, and treatment","volume":"30","author":"Lomivorotov","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2024082420210988100_ezae283-B25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jacc.2017.12.012","article-title":"New-onset atrial fibrillation after PCI or CABG for left main disease: the EXCEL Trial","volume":"71","author":"Kosmidou","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024082420210988100_ezae283-B26","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jtcvs.2010.10.040","article-title":"Short- and long-term mortality associated with new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis","volume":"141","author":"Kaw","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024082420210988100_ezae283-B27","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa2300213","article-title":"Five-year follow-up after transcatheter repair of secondary mitral regurgitation","volume":"388","author":"Stone","year":"2023","journal-title":"N Engl J Med"},{"key":"2024082420210988100_ezae283-B28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.athoracsur.2022.12.031","article-title":"Low-dose vs standard warfarin after mechanical mitral valve replacement: a randomized trial","volume":"115","author":"Chu","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"2024082420210988100_ezae283-B29","doi-asserted-by":"crossref","first-page":"e29529","DOI":"10.2196\/29529","article-title":"New internet-based warfarin anticoagulation management approach after mechanical heart valve replacement: prospective, multicenter, randomized controlled trial","volume":"23","author":"Zhu","year":"2021","journal-title":"J Med Internet Res"},{"key":"2024082420210988100_ezae283-B30","doi-asserted-by":"crossref","first-page":"933156","DOI":"10.3389\/fphar.2022.933156","article-title":"Warfarin anticoagulation management during the COVID-19 pandemic: the role of internet clinic and machine learning","volume":"13","author":"Dai","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezae283\/58881526\/ezae283.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezae283\/58914523\/ezae283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezae283\/58914523\/ezae283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T20:21:52Z","timestamp":1724530912000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezae283\/7738084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezae283","relation":{},"ISSN":["1873-734X"],"issn-type":[{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,8]]},"article-number":"ezae283"}}